Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study

被引:35
|
作者
Sorrig, Rasmus [1 ,2 ]
Klausen, Tobias W. [3 ]
Salomo, Morten [1 ]
Vangsted, Annette [1 ,2 ]
Gimsing, Peter [1 ]
机构
[1] Rigshosp, Dept Hematol, Copenhagen, Denmark
[2] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
[3] Herlev Hosp, Hematol Res Lab, Herlev, Denmark
关键词
immunoparesis; infection; multiple myeloma; risk factors; STEM-CELL TRANSPLANTATION; T-REGULATORY CELLS; HIGH-DOSE THERAPY; IMMUNE STATUS; EARLY DEATH; MORBIDITY; MORTALITY;
D O I
10.1111/ejh.13190
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Infections pose the greatest risk of early death in patients with Multiple Myeloma. However, few studies have analyzed the risk factors for infections in Multiple Myeloma patients. The aim of this study was to analyze the risk factors infections within a population-based MM cohort. Methods Using Danish registries (from 2005 to 2013), we analyzed all ICD-10 codes for infections within the first 6 months of Multiple Myeloma diagnosis in 2557 patients. Results Pneumonia and sepsis represented 46% of infections. Multivariable regression analysis showed that risk factors for pneumonia were male gender (HR 1.4; P = 0.001), ISS II (HR 1.6; P = 0.0004) and ISSIII (HR 1.8; P = 0.0004) and elevated LDH (HR 2.6; P = 0.0008). Risk factors for sepsis were high bone marrow plasma cell % (HR 1.1; P = 0.038), ISS II (HR 1.7; P = 0.007) ISS III (HR 2.0; P = 0.002) and creatinine (HR 2.1; P = 0.002). Neither immunoparesis (hypogammaglobulinemia) nor comorbidity was significant risk factors. Conclusions Our study suggests that tumor burden and renal impairment are risk factors for pneumonia and sepsis in the early phase of Multiple Myeloma.
引用
收藏
页码:182 / 190
页数:9
相关论文
共 50 条
  • [41] Determination of the individual infection risk for newly diagnosed patients with multiple myeloma
    Kaebisch, E.
    Heck, C.
    Frentsch, M.
    Blau, I. -W
    Nogai, A.
    Bullinger, L.
    Na, I. -K
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 48 - 48
  • [42] Outcomes of Patients with Newly Diagnosed Myeloma Cast Nephropathy in the Modern Era-A Retrospective Cohort Study
    Hughes, Michael
    Balev, Metodi
    Radhakrishnan, Jai
    Bhutani, Divaya
    Mapara, Markus
    Eisenberger, Andrew
    Lentzsch, Suzanne
    Chakraborty, Rajshekhar
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S139 - S139
  • [43] Retinoids are not linked to risk of multiple sclerosis: A Danish nationwide cohort study
    Cortes-Figueiredo, Filipe
    Nielsen, Nete Munk
    Stenager, Egon
    Paul, Friedemann
    Hallas, Jesper
    Kristensen, Kasper Bruun
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (01) : 247 - 256
  • [44] Oprozomib in patients with newly diagnosed multiple myeloma
    Hari, Parameswaran
    Matous, Jeffrey V.
    Voorhees, Peter M.
    Shain, Kenneth H.
    Obreja, Mihaela
    Frye, John
    Fujii, Hisaki
    Jakubowiak, Andrzej J.
    Rossi, Davide
    Sonneveld, Pieter
    BLOOD CANCER JOURNAL, 2019, 9 (9)
  • [45] Oprozomib in patients with newly diagnosed multiple myeloma
    Parameswaran Hari
    Jeffrey V. Matous
    Peter M. Voorhees
    Kenneth H. Shain
    Mihaela Obreja
    John Frye
    Hisaki Fujii
    Andrzej J. Jakubowiak
    Davide Rossi
    Pieter Sonneveld
    Blood Cancer Journal, 9
  • [46] Impact of Diabetes on Risk of End Stage Renal Disease in Danish Nationwide Cohort of Newly Diagnosed Patients with Systemic Lupus Erythematosus
    Hansen, Renata
    Simard, Julia
    Faurschou, Mikkel
    Jacobsen, Soren
    Falasinnu, Titilola
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [47] Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: A retrospective cohort study
    Lien, Ming-Yu
    Chou, Chia-Hui
    Lin, Ching-Chan
    Bai, Li-Yuan
    Chiu, Chang-Fang
    Yeh, Su-Peng
    Ho, Mao-Wang
    PLOS ONE, 2018, 13 (06):
  • [48] HLC PAIR SUPPRESSION AS A RISK FACTOR FOR BLOODSTREAM INFECTIONS AND EARLY DEATH IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
    De Veas Silva, J. L. Garcia
    Lopez Velez, M. D. S.
    Bermudo Guitarte, C.
    Barbosa de Carvalho, N.
    Rios Tamayo, R.
    Jurado Chacon, M.
    De Haro Munoz, T.
    HAEMATOLOGICA, 2017, 102 : 526 - 526
  • [49] Risk of Early Severe Infections in Newly Diagnosed Multiple Myeloma Patients Treated with Novel Agents: A Pooled Analysis
    Bonello, Francesca
    D'Agostino, Mattia
    Offidani, Massimo
    Petrucci, Maria Teresa
    Liberati, Anna Marina
    Patriarca, Francesca
    Capra, Andrea
    Benevolo, Giulia
    Gaidano, Gianluca
    Barila, Gregorio
    Galli, Monica
    Ponticelli, Elena
    Cascavilla, Nicola
    Angelucci, Emanuele
    Ballanti, Stelvio
    Pietrantuono, Giuseppe
    Pulini, Stefano
    Derudas, Daniele
    de Fabritiis, Paolo
    Corradini, Paolo
    Conticello, Concetta
    Cavo, Michele
    Sonneveld, Pieter
    Boccadoro, Mario
    Bringhen, Sara
    BLOOD, 2020, 136
  • [50] Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study
    Ege, Hilmi
    Gertz, Morie A.
    Markovic, Svetomir N.
    Lacy, Martha Q.
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Kumar, Shaji K.
    Porrata, Luis F.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (06) : 792 - 798